Molecular cytogenetics refers to the combination of cytogenetics and molecular biology techniques for chromosomal and DNA analysis at the microscopic and molecular levels. Chromosomal microarray analysis (CMA) and fluorescence in situ hybridization (FISH) are some of the widely used molecular cytogenetics techniques employed in prenatal diagnosis, cancer diagnostics and cancer research. The increasing adoption of molecular cytogenetics techniques for genetic disease risk assessment and cancer screening is driving the molecular cytogenetics market growth.
The global Molecular Cytogenetics Market is estimated to be valued at US$ 4211.4 Mn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing adoption of molecular cytogenetics techniques can be attributed to their advantages over conventional cytogenetic techniques. Global Molecular Cytogenetics Market Size techniques provide more accurate results, higher resolution and require less cell culture time compared to conventional karyotyping. They allow the detection of smaller genetic changes like microdeletions and microduplications that are often missed by standard karyotyping. As a result, molecular cytogenetics facilitates early diagnosis and treatment management decisions in prenatal testing and cancer diagnosis. With continued technological advancements reducing costs and turnaround time, the adoption of molecular cytogenetics is expected to increase further over the forecast period.
SWOT Analysis
Strength: Molecular cytogenetics offer advanced technology for genetic diagnosis and imaging of chromosomes. This helps in better treatment decisions.
Weakness: Molecular cytogenetics techniques require highly skilled professionals for analysis and high capital investments in setting up infrastructure and equipment.
Opportunity: Rising incidence of genetic disorders and cancer globally increases demand for precision molecular diagnostics. Growing healthcare spending in emerging nations also provides opportunities.
Threats: Stringent regulatory norms and lengthy product approval processes increase complexity and costs. Economic slowdowns can impact research funding and adoption of new technologies.
Key Takeaways
The global Molecular Cytogenetics Market is expected to witness high growth. The global Molecular Cytogenetics Market is estimated to be valued at US$ 4211.4 Mn in 2023 and is expected to exhibit a CAGR of 5.0% over the forecast period 2023 to 2030.
North America dominates the market currently due to presence of major players and availability of advanced healthcare facilities. Asia Pacific is poised to grow at the fastest rate over the forecast period supported by growing healthcare spending in countries like China and India.
Key players related content comprises Key players operating in the Molecular Cytogenetics market are UIC, Inc., Shimadzu Corporation, ELTRA GmbH, Xylem Inc., Skalar Analytical B.V.,Hach Company, Inc., GE Analytical Instruments, Inc., Teledyne Analytical Instruments, Mettler-Toledo International Inc., and Analytik Jena AG. These key players are focusing on new product launches, partnerships and geographic expansions to gain higher market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
